Rabenda V - Search Results

1

Adherence to treatment of osteoporosis: a need for study.

Lekkerkerker F, Kanis JA, Alsayed N, Bouvenot G, Burlet N, Cahall D, Chines A, Delmas P, Dreiser RL, Ethgen D, Hughes N, Kaufman JM, Korte S, Kreutz G, Laslop A, Mitlak B, Rabenda V, Rizzoli R, Santora A, Schimmer R, Tsouderos Y, Viethel P, Reginster JY; Group for the Respect of Ethics and Excellence in Science (GREES). Lekkerkerker F, et al. Among authors: rabenda v. Osteoporos Int. 2007 Oct;18(10):1311-7. doi: 10.1007/s00198-007-0410-4. Epub 2007 Jun 22. Osteoporos Int. 2007. PMID: 17585359 Free article. Review.

2

Positive impact of compliance to strontium ranelate on the risk of nonvertebral osteoporotic fractures.

Rabenda V, Reginster JY. Rabenda V, et al. Osteoporos Int. 2010 Dec;21(12):1993-2002. doi: 10.1007/s00198-009-1155-z. Epub 2010 Jan 16. Osteoporos Int. 2010. PMID: 20082066

3

Partial adherence: a new perspective on health economic assessment in osteoporosis.

Kanis JA, Cooper C, Hiligsmann M, Rabenda V, Reginster JY, Rizzoli R. Kanis JA, et al. Among authors: rabenda v. Osteoporos Int. 2011 Oct;22(10):2565-73. doi: 10.1007/s00198-011-1668-0. Epub 2011 May 27. Osteoporos Int. 2011. PMID: 21617992 Review.

4

[Adherence to treatment in osteoporosis influence on efficiency].

Reginster JY, Rabenda V. Reginster JY, et al. Among authors: rabenda v. Rev Med Suisse. 2005 Oct 5;1(35):2278-81. Rev Med Suisse. 2005. PMID: 16268451 French.

5

Adherence, patient preference and dosing frequency: understanding the relationship.

Reginster JY, Rabenda V, Neuprez A. Reginster JY, et al. Among authors: rabenda v. Bone. 2006 Apr;38(4 Suppl 1):S2-6. doi: 10.1016/j.bone.2006.01.150. Epub 2006 Mar 7. Bone. 2006. PMID: 16520104 Review.

6

Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women.

Rabenda V, Mertens R, Fabri V, Vanoverloop J, Sumkay F, Vannecke C, Deswaef A, Verpooten GA, Reginster JY. Rabenda V, et al. Osteoporos Int. 2008 Jun;19(6):811-8. doi: 10.1007/s00198-007-0506-x. Osteoporos Int. 2008. PMID: 17999022

7

[Prevention and treatment of osteoporosis: avoiding clinical inertia and promoting therapeutic adherence].

Rabenda V, Reginster JY. Rabenda V, et al. Rev Med Liege. 2010 May-Jun;65(5-6):358-65. Rev Med Liege. 2010. PMID: 20684420 Free article. French.

8

Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression.

Rabenda V, Bruyère O, Reginster JY. Rabenda V, et al. Osteoporos Int. 2011 Mar;22(3):893-901. doi: 10.1007/s00198-010-1469-x. Osteoporos Int. 2011. PMID: 21060990

9

Antidepressant medications and osteoporosis.

Rizzoli R, Cooper C, Reginster JY, Abrahamsen B, Adachi JD, Brandi ML, Bruyère O, Compston J, Ducy P, Ferrari S, Harvey NC, Kanis JA, Karsenty G, Laslop A, Rabenda V, Vestergaard P. Rizzoli R, et al. Among authors: rabenda v. Bone. 2012 Sep;51(3):606-13. doi: 10.1016/j.bone.2012.05.018. Epub 2012 May 30. Bone. 2012. PMID: 22659406 Review.

10

The direct and indirect costs of the chronic management of osteoporosis: a prospective follow-up of 3440 active subjects.

Rabenda V, Manette C, Lemmens R, Mariani AM, Struvay N, Reginster JY. Rabenda V, et al. Osteoporos Int. 2006;17(9):1346-52. doi: 10.1007/s00198-005-0066-x. Epub 2006 Jun 24. Osteoporos Int. 2006. PMID: 16799755

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters